|Last Price$77.00||Day Change (%)0.21%|
|Open Price$76.85||Day Change ($)0.16|
|Day Range76.63–77.29||52-Week Range62.80–77.31|
As of Thu 07/24/2014 03:52 PM EST | USD
Baxter Profit Falls, But Revenue Beats Expectations
Research and Markets: Global Analgesic Infusion Pumps Market 2014-2018 with Baxter International , Codman & Shurtleff, Flowonix Medical, Medtronic & Smiths Medical Dominating
Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
Research and Markets: Canada Wound Closure Devices Market Report
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
This week: Financial-services firms post lukewarm earnings, two tech giants strike a deal, Time Warner turns down a foxy offer, and more.